Overview

Austin MA : Plasma triglyceride and coronary heart disease. Arterioscler Thromb 1991, 11:2–15.

Brown MS Goldstein JL : The LDL receptor concept: Clinical and therapeutic implications. Atheroscler Rev 1988, 18:85–93.

Grundy SM Chait A Brunzell JD : Familial combined hyperlipidemia workshop. Arteriosclerosis 1987, 7:203–207.

Mahley RW Rall SC : Type III hyperlipoproteinemia (dysbetalipoproteinemia): The role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In The Metabolic Basis of Interited Disease, 6th edn. Edited by Scriver CR Beaudet AL Sly WS. New York: McGraw-Hill; 1989: 1195–1213.

Gidez LI Eder HA : The clinical significance of plasma high-density lipoproteins. In Clinical and Metabolic Aspects of High-Density Lipoproteins, 3rd edn. Edited by Miller NE Miller GJ. Amsterdam: Elsevier Sciences Publishers; 1984: 415–440.

Groot PHE van Stiphout WAHJ Krauss XH Jansen H van Tol A van Ramhorst E : Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991, 11:653–662.

Carlson LA Bottiger LE : Risk factors for ischemic heart disease in men and women. Acta Med Scand 1985, 218:207–211.

Krauss RM : Relationship of intermediate and low-density lipoprotein to risk of coronary artery disease. Am Heart J 1987, 113:578–583.

Yusuf S Wittes J Friedman L : Overview of results of randomised clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin and risk factor modification. JAMA 1988, 260:2259–2265.

Blankenhom DH : The angiographic evidence for lipid lowering effects in human coronary atherosclerosis regression. Curr Opin Cardiol 1991, 6:574–580.

Aqel NM Ball RY Waldman H Mitchinson MJ : Monocytic origin of foam cells in human atherosclerotic plaques. Atherosclerosis 1984, 53:265–271.

Khoo JC Miller E McLoughlin P Steinberg D : Enhanced macrophage uptake of low-density lipoprotein after self-aggregation. Arteriosclerosis 1988, 8:348–358.

Austin MA Breslow JL Hennekens CH Buring JE Willett WC Krauss RM : Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988, 260:1917–1921.

de Graaf J Hak-Lemmers HLM Hectors MPC Demacker PN Hendriks JC Stalenhoef AF : Enhanced susceptibility to in-vitro oxidation of the dense low density lipoprotein subtraction in healthy subjects. Arterioscler Thromb 1991, 11:298–306.

Scanu AM Fless GM : Lipoprotein (a): Heterogeneity and biological relevance. J Clin Invest 1990, 85:1709–1715.

Gordon DJ Probstfield JL Garrison RJ Neaton JD Castelli WP Knoke JD : High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American Studies. Circulation 1989, 79:8–15.

Austin MA King MC Vranizan KM Krauss RM : Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk. Circulation 1990, 82:495–506.

Gerrity RG. The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 1981, 103:181–190.

Fogelman AM Haberland ME Seager J Hokom M Edwards PA : Factors regulating the activities of the low-density lipoprotein receptor and the scavenger receptor on human monocyte-macrophages. J Lipid Res 1981, 22:1131–1141.

Parthasarathy S Printz DJ Boyd D Joy L Steinberg D : Macrophage oxidation of low-density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis 1986, 6:505–510.

Morel DW DiCorleto PE Chisolm GM : Endothelial and smooth muscle cells alter low-density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984, 4:357–364.

Quinn MT Parthasarathy S Fong LG Steinberg D : Oxidatively modified low-density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987, 84:2995–2998.